Navigation Links
Thoratec Announces Acquisition of Innovative Catheter-Based Heart Pump Technology
Date:1/25/2010

PLEASANTON, Calif., Jan. 25 /PRNewswire-FirstCall/ -- Thoratec Corporation (Nasdaq: THOR), a world leader in device-based mechanical circulatory support (MCS) therapies to save, support and restore failing hearts, said today that it has acquired an innovative catheter pump technology that it plans to use in the development of a minimally invasive, acute cardiac axial flow pump that can be delivered percutaneously in the cardiac catheterization lab and operating room.

Thoratec is paying a cash purchase price of $8.5 million to Getinge AB (Stockholm: GETIB) for the technology, which will be recorded as an expense in the first quarter of 2010.  The company expects to incur incremental development costs of up to $3 million in 2010.  Overall financial guidance for 2010 will be provided during the upcoming fourth quarter earnings call.

"This technology represents a compelling opportunity for Thoratec as we broaden our leadership position in MCS therapies. There is an unmet need for a device that can provide fast and minimally invasive acute cardiac support for hemodynamically unstable acute myocardial infarction, high risk percutaneous coronary intervention and post-cardiotomy patients. Given its potential ability to provide greater flow at a smaller size than other existing devices, we believe this technology offers the potential to be the basis for a breakthrough offering in this very significant market," said Gary F. Burbach, president and chief executive officer of Thoratec.

"We will be using our proven competencies in MCS while adding to our research and development team to advance this product developme
'/>"/>

SOURCE Thoratec Corporation
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Thoratec Schedules Fiscal 2009 Year-End Conference Call, Webcast
2. Thoratec Announces FDA Approval of HeartMate II(R) for Destination Therapy
3. Thoratec Presentation at Piper Jaffray Conference to be Webcast
4. Thoratec Investor Meeting to Review HeartMate II (R) Destination Therapy Trial Data to Be Webcast
5. Thoratec Presentation at Canaccord Adams Conference to be Webcast
6. Thoratec Reports 14 Percent Growth in Cardiovascular Division Sales as Third Quarter Revenues Increase Nine Percent
7. Thoratec Says Interim Data Analysis Demonstrates Statistical Superiority for the HeartMate II(R) in Destination Therapy Trial
8. Thoratec Announces FDA Approval of HeartMate II(R) for Bridge-To-Transplantation
9. Tenaxis Medical, Inc. Announces Completion of the Enrollment Phase of Their Pivotal Study
10. Telik Announces Initiation of Phase 1 Clinical Study of Ezatiostat Hydrochloride (TELINTRA(R), TLK199) Tablets in Combination With Lenalidomide (Revlimid(R)) in Patients With Myelodysplastic Syndrome (MDS)
11. Warner Chilcott Announces 2010 Financial Guidance Conference Call
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/30/2014)... 2014 Cynosure, Inc. (NASDAQ: ... for non-invasive and minimally invasive applications, today announced that the ... Officer and Chief Financial Officer Timothy W. Baker ... 53, will continue to serve as CFO and will take ... remains Chairman and Chief Executive Officer. "Tim ...
(Date:7/30/2014)... N.J. and SAN DIEGO , ... (NASDAQ: ARNA ) announced today that an article ... trials of lorcaserin entitled, "Early Weight Loss While on Lorcaserin, ... Outcomes," was recently published in the online issue of ... Society. The objective of these analyses was to identify whether ...
(Date:7/30/2014)... /PRNewswire-iReach/ -- This is a professional and in-depth ... (CAS 9041-08-1) & calcium (CAS 37270-89-6) industry. The ... sodium (CAS 9041-08-1) & calcium (CAS 37270-89-6) including ... then explores global and China,s top manufacturers of ... listing their product specification, capacity, production value, cost, ...
Breaking Medicine Technology:Cynosure Appoints Chief Operating Officer and Chief Financial Officer Timothy W. Baker as President 2Eisai and Arena Pharmaceuticals Announce Publication of Post-Hoc Analyses of Lorcaserin Phase 3 Clinical Trial Results in Obesity 2Eisai and Arena Pharmaceuticals Announce Publication of Post-Hoc Analyses of Lorcaserin Phase 3 Clinical Trial Results in Obesity 3Eisai and Arena Pharmaceuticals Announce Publication of Post-Hoc Analyses of Lorcaserin Phase 3 Clinical Trial Results in Obesity 4Eisai and Arena Pharmaceuticals Announce Publication of Post-Hoc Analyses of Lorcaserin Phase 3 Clinical Trial Results in Obesity 5Eisai and Arena Pharmaceuticals Announce Publication of Post-Hoc Analyses of Lorcaserin Phase 3 Clinical Trial Results in Obesity 6Eisai and Arena Pharmaceuticals Announce Publication of Post-Hoc Analyses of Lorcaserin Phase 3 Clinical Trial Results in Obesity 7Heparin Sodium & Calcium Industry for Global and Chinese Markets Forecast to 2019 2Heparin Sodium & Calcium Industry for Global and Chinese Markets Forecast to 2019 3Heparin Sodium & Calcium Industry for Global and Chinese Markets Forecast to 2019 4Heparin Sodium & Calcium Industry for Global and Chinese Markets Forecast to 2019 5
... , ST. LOUIS, Jan. 11 KV Pharmaceutical Company ... the existing asset purchase agreement with Hologic, Inc. to secure the ... and conditions set forth in the amendment. Upon approval by the ... first and only FDA-approved treatment for the prevention of preterm birth ...
... N.J., Jan. 11 Survival of the fittest? In ... only what you know today, but what you need to ... has the right insight and accurate forecasting skills will excel. ... growing) market in the world, its sheer size also presents ...
Cached Medicine Technology:KV Pharmaceutical Amends Agreement to Secure Rights to Gestiva(TM) 2KV Pharmaceutical Amends Agreement to Secure Rights to Gestiva(TM) 3KV Pharmaceutical Amends Agreement to Secure Rights to Gestiva(TM) 4KV Pharmaceutical Amends Agreement to Secure Rights to Gestiva(TM) 5KV Pharmaceutical Amends Agreement to Secure Rights to Gestiva(TM) 6KV Pharmaceutical Amends Agreement to Secure Rights to Gestiva(TM) 7Elite Pharma Insiders to Reveal Key Survival Strategies for Pharmaceutical Industry in 2010 2
(Date:7/30/2014)... Bay Aquarium Research Institute (MBARI) have observed a deep-sea ... yearslonger than any other known animal. Throughout this time, ... from predators. This amazing feat represents an evolutionary balancing ... having plenty of time to develop within their eggs, ... little or no food. , Every few months for ...
(Date:7/30/2014)... Frozen shoulder (Adhesive capsulitis) affects 10-20 percent ... this nasty condition which occurs most frequently in people between ... to two and half years if not treated. , Adhesive ... good reason: it can render your shoulder so stiff, it's ... you aren't in too much pain to get dressed in ...
(Date:7/30/2014)... WEDNESDAY, July 30, 2014 (HealthDay News) -- For patients ... is enough to trigger airway inflammation for at least ... just what you smell, but also what you think ... Monell Chemical Senses Center in Philadelphia, said in a ... about scents and fragrances. When we expect that an ...
(Date:7/30/2014)... vast majority of kids with autism have abnormal sensory ... children who have trouble processing sensory stimuli, researchers report. ... overly sensitive to sound, sight and touch. They can ... of concentration. Complicating matters, some kids with SPD ... tolerating loud noises, like a vacuum. Others can,t hold ...
(Date:7/30/2014)... adults who were breastfed for three months or ... of chronic inflammation associated with cardiovascular and metabolic ... at Washington University in St. Louis. , "This ... implications for children,s health decades later," said Molly ... School and a co-author of the study with ...
Breaking Medicine News(10 mins):Health News:Deep-sea octopus broods eggs for over 4 years -- longer than any known animal 2Health News:Deep-sea octopus broods eggs for over 4 years -- longer than any known animal 3Health News:Good News for Diabetics Suffering from Frozen Shoulder 2Health News:Good News for Diabetics Suffering from Frozen Shoulder 3Health News:Good News for Diabetics Suffering from Frozen Shoulder 4Health News:Even Thinking an Odor is Harmful May Spur Asthma Symptoms 2Health News:Different Areas of Brain Affected in Autism, Sensory Disorders 2Health News:Different Areas of Brain Affected in Autism, Sensory Disorders 3Health News:Birthweight and breastfeeding have implications for children's health decades later 2
... to stop overdoses in heroin addicts. Hence many needle ... The news follows the deaths of at least 400 ... ,Prevention Point Philadelphia, a nonprofit organization responsible for ... distribution of naloxone prescriptions through a physician. "If people ...
... Gainesville, mice based experiments were found to be successful in ... , This new technique was found to be successful ... The findings, published July 27 in the online edition of ... could begin as soon as early next year for patients ...
... researchers at the University of Geneva it was found that ... smokers. // ,NRT is mainly to wean smokers off ... their normal health. But according to these researchers they have ... 7.2% among smokers for a period of four years. ...
... effectiveness of a bird flu vaccine against the deadly H5N1 ... and unvaccinated monkeys, by researchers at two universities.// ... Hokkaido University, the results are expected to be known within ... could shed light on numerous aspects of the strain's infection ...
... drug is beginning to light up the lives of thousands ... of the kidney and the gut.// Initial examinations of the ... breast, lung and pancreatic cancers. ,This drug ... an important enzyme that causes the cells to proliferate rapidly, ...
... U.S. Department of Agriculture have indicated the enhanced nutritive ... Watermelon. // ,According to scientists, watermelons are ... severed from the parent plant, which slows down once ... kept at 70 degrees, contained almost 40% of lycopene ...
Cached Medicine News:Health News:Gene Therapy Technique for Inherited Heart Problems in The Pipeline 2Health News:Gene Therapy Technique for Inherited Heart Problems in The Pipeline 3Health News:Gene Therapy Technique for Inherited Heart Problems in The Pipeline 4
... AEM Laparoscopic Instruments incorporate a layered design ... shielded and monitored to prevent stray electrosurgical ... caused by insulation failure or capacitive coupling; ... shield built into all AEM Instruments provides ...
... Instruments incorporate a layered design unique in ... monitored to prevent stray electrosurgical burns along ... insulation failure or capacitive coupling; a well-documented ... into all AEM Instruments provides a neutral ...
SOLOS Endoscopy shares your commitment to provide every patient with the highest quality care available through our ongoing research and development of advanced surgical instruments and diagnostic so...
SOLOS Endoscopy shares your commitment to provide every patient with the highest quality care available through our ongoing research and development of advanced surgical instruments and diagnostic so...
Medicine Products: